Epidemiology and Pathophysiology of Childhood Narcolepsy

Paediatric Respiratory Reviews

Volumn 25, Issue , 2018, Pages 14-18

  Dye, Thomas J ^a   Gurbani, Neepa ^a   Simakajornboon, Narong ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Autoimmune mechanism; Childhood narcolepsy; H1N1 pandemic; H1N1 vaccination; HLA; Narcolepsy; Narcolepsy epidemiology; Narcolepsy genetics; Narcolepsy pathogenesis; Narcolepsy with cataplexy; Streptococcal infection

Indexed keywords

ANTIBODY; ANTIGEN; ANTISTREPTOLYSIN; AUTOANTIBODY; DEOXYRIBONUCLEASE B ANTIBODY; HLA DQB1 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OX40 LIGAND; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; TRIBBLES HOMOLOGUE 2; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; HLA DQ ANTIGEN; HLA-DQB1 ANTIGEN; INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; AUTOIMMUNITY; CTSH GENE; ENVIRONMENTAL FACTOR; GENE; GENETIC POLYMORPHISM; GENETICS; HUMAN; INCIDENCE; MOLECULAR MIMICRY; NARCOLEPSY; P2RY11 GENE; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS INFECTION; T LYMPHOCYTE ACTIVATION; TCR ALPHA GENE; TNFSF4 GENE; COMPLICATION; GENOTYPE ENVIRONMENT INTERACTION; IMMUNOLOGY; INFLUENZA; INFLUENZA A VIRUS (H1N1);

AUTOIMMUNITY; GENE-ENVIRONMENT INTERACTION; HLA-DQ BETA-CHAINS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; NARCOLEPSY; STREPTOCOCCAL INFECTIONS;

EID: 85009769754     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2016.12.005     Document Type: Review

References (63)

1. Longstreth, W.T. Jr., Koepsell, T.D., Ton, T.G., Hendrickson, A.F., van Belle, G., The epidemiology of narcolepsy. Sleep 30:1 (2007), 13–26.
2. Ohayon, M.M., Priest, R.G., Zulley, J., Smirne, S., Paiva, T., Prevalence of narcolepsy symptomatology and diagnosis in the European general population. Neurology 58:12 (2002), 1826–1833.
3. Hublin, C., Partinen, M., Kaprio, J., Koskenvuo, M., Guilleminault, C., Epidemiology of narcolepsy. Sleep 17:8 Suppl (1994), S7–S12.
4. Silber, M.H., Krahn, L.E., Olson, E.J., Pankratz, V.S., The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study. Sleep 25:2 (2002), 197–202.
5. Wing, Y.K., Li, R.H., Lam, C.W., Ho, C.K., Fong, S.Y., Leung, T., The prevalence of narcolepsy among Chinese in Hong Kong. Ann Neurol 51:5 (2002), 578–584.
6. Shin, Y.K., Yoon, I.Y., Han, E.K., et al. Prevalence of narcolepsy-cataplexy in Korean adolescents. Acta neurologica Scandinavica 117:4 (2008), 273–278.
7. Partinen, M., Kornum, B.R., Plazzi, G., Jennum, P., Julkunen, I., Vaarala, O., Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination. The Lancet Neurology 13:6 (2014), 600–613.
8. Han, F., Chen, E., Wei, H., et al. Childhood narcolepsy in North China. Sleep 24:3 (2001), 321–324.
9. Wu, H., Zhuang, J., Stone, W.S., et al. Symptoms and occurrences of narcolepsy: a retrospective study of 162 patients during a 10-year period in Eastern China. Sleep Med, 2014.
10. Longstreth, W.T. Jr., Ton, T.G., Koepsell, T., Gersuk, V.H., Hendrickson, A., Velde, S., Prevalence of narcolepsy in King County, Washington, USA. Sleep Med 10:4 (2009), 422–426.
11. Wilner, A., Steinman, L., Lavie, P., Peled, R., Friedmann, A., Brautbar, C., Narcolepsy-cataplexy in Israeli Jews is associated exclusively with the HLA DR2 haplotype. A study at the serological and genomic level. Human immunology 21:1 (1988), 15–22.
12. Honda, Y., Census of narcolepsy, cataplexy and sleep life among teenagers in Fujisawa Cty. Sleep Res, 8, 1979, 191.
13. Dauvilliers, Y., Montplaisir, J., Molinari, N., et al. Age at onset of narcolepsy in two large populations of patients in France and Quebec. Neurology 57:11 (2001), 2029–2033.
14. Wijnans, L., Lecomte, C., de Vries, C., et al. The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine 31:8 (2013), 1246–1254.
15. Partinen, M., Saarenpaa-Heikkila, O., Ilveskoski, I., et al. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PloS one, 7(3), 2012, e33723.
16. Szakacs, A., Darin, N., Hallbook, T., Increased childhood incidence of narcolepsy in western Sweden after H1N1 influenza vaccination. Neurology 80:14 (2013), 1315–1321.
17. Oberle, D., Drechsel-Bauerle, U., Schmidtmann, I., Mayer, G., Keller-Stanislawski, B., Incidence of Narcolepsy in Germany. Sleep 38:10 (2015), 1619–1628.
18. Han, F., Lin, L., Warby, S.C., et al. Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol 70:3 (2011), 410–417.
19. Hagan, J.J., Leslie, R.A., Patel, S., et al. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci U S A 96:19 (1999), 10911–10916.
20. Sutcliffe, J.G., de Lecea, L., The hypocretins: excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding. Journal of neuroscience research 62:2 (2000), 161–168.
21. Brown, R.E., Sergeeva, O., Eriksson, K.S., Haas, H.L., Orexin A excites serotonergic neurons in the dorsal raphe nucleus of the rat. Neuropharmacology 40:3 (2001), 457–459.
22. Shibata, M., Mondal, M.S., Date, Y., Nakazato, M., Suzuki, H., Ueta, Y., Distribution of orexins-containing fibers and contents of orexins in the rat olfactory bulb. Neuroscience research 61:1 (2008), 99–105.
23. Singh, A.K., Mahlios, J., Mignot, E., Genetic association, seasonal infections and autoimmune basis of narcolepsy. Journal of autoimmunity 43 (2013), 26–31.
24. Lin, L., Faraco, J., Li, R., et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98:3 (1999), 365–376.
25. Chemelli, R.M., Willie, J.T., Sinton, C.M., et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98:4 (1999), 437–451.
26. Nishino, S., Ripley, B., Overeem, S., et al. Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy. Ann Neurol. 50:3 (2001), 381–388.
27. Peyron, C., Faraco, J., Rogers, W., et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nature medicine 6:9 (2000), 991–997.
28. Thannickal, T.C., Moore, R.Y., Nienhuis, R., et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 27:3 (2000), 469–474.
29. Nishino, S., Okura, M., Mignot, E., Narcolepsy: genetic predisposition and neuropharmacological mechanisms. REVIEW ARTICLE. Sleep Med Rev 4:1 (2000), 57–99.
30. Mignot, E., Genetic and familial aspects of narcolepsy. Neurology 50:2 Suppl 1 (1998), S16–S22.
31. Juji, T., Satake, M., Honda, Y., Doi, Y., HLA antigens in Japanese patients with narcolepsy: All the patients were DR2 positive. Tissue antigens 24:5 (1984), 316–319.
32. Mignot, E.J., History of narcolepsy at Stanford University. Immunologic research 58:2–3 (2014), 315–339.
33. Mignot, E., Lin, X., Arrigoni, J., et al. DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans. Sleep 17:8 Suppl (1994), S60–S67.
34. Mignot, E., Lin, L., Rogers, W., et al. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. American journal of human genetics 68:3 (2001), 686–699.
35. Mignot, E., Hayduk, R., Black, J., Grumet, F.C., Guilleminault, C., HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep 20:11 (1997), 1012–1020.
36. Dauvilliers, Y., Arnulf, I., Mignot, E., Narcolepsy with cataplexy. The Lancet 369:9560 (2007), 499–511.
37. Hor, H., Kutalik, Z., Dauvilliers, Y., et al. Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy. Nat Genet 42:9 (2010), 786–789.
38. Miyagawa, T., Kawashima, M., Nishida, N., et al. Variant between CPT1B and CHKB associated with susceptibility to narcolepsy. Nat Genet 40:11 (2008), 1324–1328.
39. Han, F., Lin, L., Li, J., et al. TCRA, P2RY11, and CPT1B/CHKB associations in Chinese narcolepsy. Sleep Med 13:3 (2012), 269–272.
40. Hallmayer, J., Faraco, J., Lin, L., et al. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet 41:6 (2009), 708–711.
41. Petrie, H.T., Livak, F., Burtrum, D., Mazel, S., T cell receptor gene recombination patterns and mechanisms: cell death, rescue, and T cell production. The Journal of experimental medicine 182:1 (1995), 121–127.
42. Junger, W.G., Immune cell regulation by autocrine purinergic signalling. Nature reviews Immunology 11:3 (2011), 201–212.
43. Winkelmann, J., Lin, L., Schormair, B., et al. Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy. Human molecular genetics 21:10 (2012), 2205–2210.
44. Faraco, J., Lin, L., Kornum, B.R., et al. ImmunoChip study implicates antigen presentation to T cells in narcolepsy. PLoS genetics, 9(2), 2013, e1003270.
45. Picchioni, D., Hope, C.R., Harsh, J.R., A case-control study of the environmental risk factors for narcolepsy. Neuroepidemiology 29:3–4 (2007), 185–192.
46. Aran, A., Lin, L., Nevsimalova, S., et al. Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset. Sleep 32:8 (2009), 979–983.
47. Ahmed, S.S., Schur, P.H., MacDonald, N.E., Steinman, L., Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants. Journal of autoimmunity 50 (2014), 1–11.
48. Nohynek, H., Jokinen, J., Partinen, M., et al. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PloS one, 7(3), 2012, e33536.
49. Dauvilliers, Y., Montplaisir, J., Cochen, V., et al. Post-H1N1 narcolepsy-cataplexy. Sleep 33:11 (2010), 1428–1430.
50. Miller, E., Andrews, N., Stellitano, L., et al. Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis. Bmj, 346, 2013, f794.
51. O'Flanagan, D., Barret, A.S., Foley, M., et al. Investigation of an association between onset of narcolepsy and vaccination with pandemic influenza vaccine, Ireland April 2009-December 2010. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 19:17 (2014), 15–25.
52. Johansen, K., Brasseur, D., MacDonald, N., et al. Where are we in our understanding of the association between narcolepsy and one of the 2009 adjuvanted influenza A (H1N1) vaccines?. Biologicals: journal of the International Association of Biological Standardization 44:4 (2016), 276–280.
53. Han, F., Lin, L., Li, J., Dong, X.S., Mignot, E., Decreased incidence of childhood narcolepsy 2 years after the 2009 H1N1 winter flu pandemic. Ann Neurol, 73(4), 2013, 560.
54. Choe, Y.J., Bae, G.R., Lee, D.H., No association between influenza A(H1N1)pdm09 vaccination and narcolepsy in South Korea: an ecological study. Vaccine 30:52 (2012), 7439–7442.
55. Kornum, B.R., Faraco, J., Mignot, E., Narcolepsy with hypocretin/orexin deficiency, infections and autoimmunity of the brain. Current opinion in neurobiology 21:6 (2011), 897–903.
56. Mahlios, J., De la Herran-Arita, A.K., Mignot, E., The autoimmune basis of narcolepsy. Current opinion in neurobiology 23:5 (2013), 767–773.
57. Fontana, A., Gast, H., Reith, W., Recher, M., Birchler, T., Bassetti, C.L., Narcolepsy: autoimmunity, effector T cell activation due to infection, or T cell independent, major histocompatibility complex class II induced neuronal loss?. Brain: a journal of neurology 133:Pt 5 (2010), 1300–1311.
58. Ollila, H.M., Ravel, J.M., Han, F., et al. HLA-DPB1 and HLA class I confer risk of and protection from narcolepsy. American journal of human genetics 96:1 (2015), 136–146.
59. Snider, L.A., Swedo, S.E., Post-streptococcal autoimmune disorders of the central nervous system. Current opinion in neurology 16:3 (2003), 359–365.
60. Cvetkovic-Lopes, V., Bayer, L., Dorsaz, S., et al. Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients. The Journal of clinical investigation 120:3 (2010), 713–719.
61. Rose, N.R., Bona, C., Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunology today 14:9 (1993), 426–430.
62. Scammell, T.E., Narcolepsy. N Engl J Med 373:27 (2015), 2654–2662.
63. Barker, C.I.S., Snape, M.D., Pandemic influenza A H1N1 vaccines and narcolepsy: vaccine safety surveillance in action. The Lancet Infectious Diseases 14:3 (2014), 227–238.